Bentham Science Logo

Current Cancer Drug Targets

Volume 19, 11 Issues, 2019
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Ranking and Category

  • 135th of 229 in

    Oncology

Order Your Article Before Print

Aims & Scope

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.

Current Cancer Drug Targets publishes original research articles, letters, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.

As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Cancer Drug Targets

,

Volume 19

-

Number 7



Perspective   Open Access



Review Article



Review Article

Nanotherapy Targeting the Tumor Microenvironment

, 19(7): 525 - 533

Bo-Shen Gong, Rui Wang, Hong-Xia Xu, Ming-Yong Miao* and Zhen-Zhen Yao*


DOI: 10.2174/1568009619666181220103714


Review Article



Research Article



Research Article



Research Article

Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells

, 19(7): 571 - 582

Jia Wei, Ling Ma, Chenglong Li, Christopher R. Pierson, Jonathan L. Finlay and Jiayuh Lin*


DOI: 10.2174/1568009618666181016165604


Research Article



Articles Ahead of Print

Sam68 Promotes the Progression of Human Breast Cancer through inducing Activation of EphA3


Xinxin Chen*, Lehong Zhang*, Ziqiao Kuang, Ying Zou, Tian Tang, Wangjian Zhang, Xiaowu Hu, Ting Xia , Tengfei Cao, Haixia Jia and Min Yuan


DOI: 10.2174/1568009619666190718124541
View Abstract


The Role of Shcbp1 in Signaling and Disease


Geng-Yuan Zhang, Zhi-Jian Ma, Long Wang, Ruo-Fei Sun, Xiang-Yan Jiang, Xu-Juan Yang, Bo Long, Hui-Li Ye, Shu-Ze Zhang, Ze-Yuan Yu, Wen-Gui Shi and Zuo-Yi Jiao*


DOI: 10.2174/1568009619666190620114928
View Abstract View on PubMed


Magnesium-dependent Phosphatase (MDP) 1 is a Potential Suppressor of Gastric Cancer


Jianbo Zhu*, Lijuan Deng*, Baozhen Chen*, Wenqing Huang, Xiandong Lin, Gang Chen, Chi-Meng Tzeng, Mingang Ying and Zhongxian Lu


DOI: 10.2174/1568009619666190620112546
View Abstract View on PubMed




Polyisoprenylated Cysteinyl Amide Inhibitors Deplete K-Ras and Induce Caspase-dependent Apoptosis in Lung Cancer Cells


Augustine T. Nkembo, Felix Amissah, Elizabeth Ntantie, Rosemary A. Poku, Olufisayo O. Salako, Offiong Francis Ikpatt and Nazarius S. Lamango*


DOI: 10.2174/1568009619666190325144636
View Abstract View on PubMed



Mechanisms and Treatment Progress of Rituximab-Resistance in Diffuse Large B-cell Lymphoma


Li Yang*, Linqing Zou*, Siyu Gu, Lingling Kong, Shiqi Sun, Guoqi Song and William C Cho


DOI: 10.2174/1568009619666190126125251
View Abstract


Withdrawn: The Structural Bioinformatics Analysis of Biophenolic Lignan- Estrogen Receptor Interaction


Farzaneh Mohamadyar-Toupkanlou*, Mina Esfandiari, Mahshid Sadat Kashef-Saberi, Mahboubeh Kabiri Renani and Masoud Soleimani


DOI: 10.2174/1568009617666170623121446
View Abstract View on PubMed



Published Contents

Editor's Choice


Exploring Proteomic Drug Targets, Therapeutic Strategies and Protein - Protein Interactions in Cancer: Mechanistic View

, 2019; 19(6): 430 - 448

Khalid Bashir Dar, Aashiq Hussain Bhat, Shajrul Amin, Syed Anjum, Bilal Ahmad Reshi, Mohammad Afzal Zargar, Akbar Masood and Showkat Ahmad Ganie*


DOI: 10.2174/1568009618666180803104631







Specific Targeting of HER2-Positive Head and Neck Squamous Cell Carcinoma Line HN5 by Idarubicin-ZHER2 Affibody Conjugate

, 2019; 19(1): 65 - 73

Marzieh Ghanemi, Aminollah Pourshohod, Mohammad Ali Ghaffari, Alireza kheirollah, Mansour Amin, Majid Zeinali* and Mostafa Jamalan*


DOI: 10.2174/1568009617666170427105417





p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents

, 2018; 18(8): 749 - 772

Surendra Kumar Nayak*, Gopal L. Khatik, Rakesh Narang, Vikramdeep Monga and Harish Kumar Chopra


DOI: 10.2174/1568009617666170623111953



Open Access Articles

Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer

, 2019; 19(1): 74 - 80

Peng Liu, Hailin Tang, Jiali Wu, Xingsheng Qiu, Yanan Kong, Lijuan Zhang, Xinhua Xie* and Xiangsheng Xiao*




Role of MicroRNAs in Treatment Response in Prostate Cancer

, 2018; 18(10): 929 - 944

Anshuli Razdan, Paul de Souza* and Tara Laurine Roberts




Noxa: Role in Cancer Pathogenesis and Treatment

, 2018; 18(10): 914 - 928

Rami Z. Morsi, Rouba Hage-Sleiman, Hadile Kobeissy and Ghassan Dbaibo*








Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in vitro and in vivo

, 2014; 14(9): 860 - 871

Rui Zhou, Zongliang Lu, Kai Liu, Jing Guo, Jie Liu, Yong Zhou, Jian Yang, Mantian Mi and Hongxia Xu




Pleiotropic Role of HSF1 in Neoplastic Transformation

, 2014; 14(2): 144 - 155

Natalia Vydra, Agnieszka Toma and Wieslawa Widlak






β-Catenin Knockdown in Liver Tumor Cells by a Cell Permeable Gamma Guanidine-based Peptide Nucleic Acid

, 2013; 13(8): 867 - 878

Evan Delgado, Raman Bahal, Jing Yang, Jung M. Lee, Danith H Ly and Satdarshan P. S. Monga




Signal Transduction in Human Cutaneous Melanoma and Target Drugs

, 2013; 13(8): 843 - 866

Anatoly B. Uzdensky, Svetlana V. Demyanenko and Mikhail Y. Bibov




Use of Single Nucleotide Polymorphism Array Technology to Improve the Identification of Chromosomal Lesions in Leukemia

, 2013; 13(7): 791 - 810

Ilaria Iacobucci, Annalisa Lonetti, Cristina Papayannidis and Giovanni Martinelli




Autophagy in Chronic Myeloid Leukaemia: Stem Cell Survival and Implication in Therapy

, 2013; 13(7): 724 - 734

Gudmundur V. Helgason, Arunima Mukhopadhyay, Maria Karvela, Paolo Salomoni, Bruno Calabretta and Tessa L. Holyoake





Most Cited Articles


Research Article

TGF-β1 causes EMT by regulating N-acetyl glucosaminyl transferases via downregulation of non muscle myosin II-a through JNK/P38/PI3K pathway in lung cancer

, 1 March 2018; 18(2): 209-219.

Ghulam Jilany Khan, Yingsheng Gao, Ming Gu, Lai Wang, Sara Khan, Farah Naeem, Herve Semukunzi, Debmalya Roy, Shengtao Yuan* and Li Sun*


DOI: 10.2174/1568009617666170807120304


Review Article

Oxidative stress and cancer: The role of Nrf2

, 2018; 18(6): 538-557.

Soraya Sajadimajd and Mozafar Khazaei*


DOI: 10.2174/1568009617666171002144228


Review Article

Clinical trials with oncolytic measles virus: Current status and future prospects

, 2018; 18(2): 177-187.

Pavlos Msaouel, Mateusz Opyrchal, Angela Dispenzieri, Kah Whye Peng, Mark J. Federspiel, Stephen J. Russell and Evanthia Galanis*


DOI: 10.2174/1568009617666170222125035


Review Article

Metastatic colorectal cancer: Role of target therapies and future perspectives

, 2018; 18(5): 421-429.

Anna Nappi, Massimiliano Berretta, Carmela Romano, Salvatore Tafuto, Antonino Cassata, Rossana Casaretti, Lucrezia Silvestro, Chiara De Divitiis, Lara Alessandrini, Francesco Fiorica, Alessandro Ottaiano and Guglielmo Nasti*


DOI: 10.2174/1568009617666170209095143


Review Article

Cell-derived exosomes as promising carriers for drug delivery and targeted therapy

, 1 May 2018; 18(4): 347-354.

Xinyi Wang, Haiyang Zhang, Haiou Yang, Ming Bai, Tao Ning, Shuang Li, Jialu Li, Ting Deng, Guoguang Ying* and Yi Ba*


DOI: 10.2174/1568009617666170710120311


Review Article

PARP inhibitors for the treatment of ovarian cancer

, 2018; 18(9): 877-893.

Laura Cortesi, Angela Toss* and Iole Cucinotto


DOI: 10.2174/1568009618666180308104646



Review Article

MicroRNA key to angiogenesis regulation: MiRNA biology and therapy

, 2018; 18(3): 266-277.

Ankit Tiwari, Bratati Mukherjee and Manjusha Dixit*


DOI: 10.2174/1568009617666170630142725


Review Article

Multimodal HDAC inhibitors with improved anticancer activity

, 1 January 2018; 18(1): 39-56.

Rainer Schobert and Bernhard Biersack*


DOI: 10.2174/1568009617666170206102613


Review Article

Synthetic lethality: From research to precision cancer nanomedicine

, 1 May 2018; 18(4): 337-346.

Anuradha Gupta, Anas Ahmad, Aqib Iqbal Dar and Rehan Khan*


DOI: 10.2174/1568009617666170630141931



Review Article

Antibody based EpCAM targeted therapy of cancer, review and update

, 2018; 18(9): 857-868.

Shirin Eyvazi, Safar Farajnia*, Siavoush Dastmalchi, Farzad Kanipour, Habib Zarredar and Mojghan Bandehpour


DOI: 10.2174/1568009618666180102102311



Review Article

Oncolytic viruses: The best is yet to come

, 1 March 2018; 18(2): 109-123.

Chantal G. Lemay, Brian A. Keller, Robert E. Edge, Masato Abei and John C. Bell*


DOI: 10.2174/1568009617666170206111609



Most Accessed Articles

Polyploid Giant Cancer Cells (PGCCs): The Evil Roots of Cancer

, 2019; 19(5): 360-367.

Junsong Chen, Na Niu, Jing Zhang, Lisha Qi, Weiwei Shen, Krishna Vanaja Donkena, Zhenqing Feng and Jinsong Liu*


DOI: 10.2174/1568009618666180703154233




The RNA Binding Protein HuR: a Promising Drug Target for Anticancer Therapy

, 2019; 19(5): 382-399.

Mingxia Wu, Christy W.S. Tong, Wei Yan, Kenneth K.W. To* and William C.S. Cho*


DOI: 10.2174/1568009618666181031145953









Related Journals

Related eBooks

eBooks Catalog